The Way Out of Obamacare
Autor Sally Pipesen Limba Engleză Paperback – 14 dec 2015
President Barack Obama has declared that his signature health reform law – the Patient Protection and Affordable Care Act – is “here to stay.” But his days in the White House are numbered, and the law has failed: insurance premiums and deductibles have skyrocketed, patients are losing access to doctors, and economic growth has been crushed.
In this Broadside, Sally C. Pipes provides an actionable blueprint for health care reform this campaign season, which the next president can implement on Day One. This book provides a replacement plan for Obamacare – one that will provide affordable, accessible, quality health care for all Americans.
In this Broadside, Sally C. Pipes provides an actionable blueprint for health care reform this campaign season, which the next president can implement on Day One. This book provides a replacement plan for Obamacare – one that will provide affordable, accessible, quality health care for all Americans.
Preț: 25.64 lei
Preț vechi: 33.53 lei
-24% Nou
Puncte Express: 38
Preț estimativ în valută:
4.91€ • 5.11$ • 4.09£
4.91€ • 5.11$ • 4.09£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781594038297
ISBN-10: 1594038295
Pagini: 56
Dimensiuni: 117 x 173 x 5 mm
Greutate: 0.07 kg
Editura: ENCOUNTER BOOKS
ISBN-10: 1594038295
Pagini: 56
Dimensiuni: 117 x 173 x 5 mm
Greutate: 0.07 kg
Editura: ENCOUNTER BOOKS
Notă biografică
Sally C. Pipes is president and chief executive officer of the Pacific Research Institute, a San Francisco–based think tank, and the Thomas W. Smith Fellow in Health Care Policy at PRI. She previously served as the assistant director of the Fraser Institute in Canada. She is the author of The Cure for Obamacare (Encounter, 2013), The Truth about Obamacare (Regnery 2010), The Pipes Plan: The Top 10 Ways to Dismantle and Replace Obamacare (Regnery 2012). She writes a biweekly health care column for Forbes.